Sigaux, Johanna https://orcid.org/0000-0002-6371-740X
Mathieu, Sylvain
Nguyen, Yann
Sanchez, Pauline
Letarouilly, Jean-Guillaume
Soubrier, Martin
Czernichow, Sébastien
Flipo, René-Marc
Sellam, Jérémie
Daïen, Claire
Article History
Received: 2 November 2021
Accepted: 19 April 2022
First Online: 7 May 2022
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.JSi: consulting fees: Sandoz, Novartis; SM: none; YN: none; PS: none; JGL: consulting fees: Sêmeia; MS: none; SC: consulting fees: Lilly, Janssen, BMS, Fresenius Kabi, Novonordisk, Servier, Bariatek, Fitforme, Mygoodlife; RMF: none; Jse: consulting fees: Roche, Chugai, Pfizer, BMS, MSD, Biogen, Abbvie, Sandoz, Janssen, Novartis, Fresenius Kabi, Sanofi, research grants: Pfizer, MSD, Schwa Medico; CD: consulting fees: Abbvie, Abivax, BMS, Fresenius Kabi, Novartis, Pfizer, Sandoz, Sanofi, Roche- Chugai, UCB.